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Conclusion: Although quantitatively different, late TI has acceptable count
statistics and comparable visual image quality to rest TI, establishing the fea-
sibilityof late TI/stress Tc-sestamibi dual isotope SPECT in non-obese «200
Ibs) patients. The protocol allows for final reporting on the same day as stress
testing, potentially decreasing the length of hospitalization.
Determination of Extent of Viable Myocardium
within Infarct-Related Arterial Perfusion Beds
Using Intracoronary Tc-99m-Sestamibi Injection
Jeffrey I. Leavitt, Chanh Syravanh, Joseph A. Vita, Martha Nykiel, Donald E. Tow,
Thomas P Rocco. West Roxbury VA Hospital, Boston, MA
logic stress. In the patients undergoing treadmill testing, mean exercise time
was 10 ± 3 minutes and the maximum predicted heart rate achieved was 93
± 2%. Chest pain symptoms occurred in 11 patients (16%). In 68 patients,
the stress images were interpreted as normal and rest imaging was not per-
formed: in 2 patients stress images were abnormal. Short-term follow-up
(5.6 ± 2 months, range 1,5-11 months) was obtained in 68 of 70 patients
(97%): among the 66 patients with normal stress-only images, there were
no deaths, myocardial infarction, or revascularization; one hospitalization for
chest pain resulted in catheterization demonstrating non-critical CAD. Both
patients with abnormal stress-only images were subsequently found to have
significant angiographic CAD, Hence, in patients selected for a low pre-test
probability of CAD, a stress-only protocol will result in the need for few sets
of resting images, optimizing camera usage and throughput, with potential
cost savings, In the absence of information provided by resting images, a
normal stress-only SPECT sestamibi image in this setting is associated with
a benign short-term outcome, similar to that reported for a full stress-rest
sestamibi protocol.
Precise determination of the extent of residual viable myocardium within the
infarct-related vascular territory in patients with myocardial infarction may be
important in assessing potential benefit from revascularization. yet measure-
ment of this parameter has proven difficult. To address this issue, 15 patients
with predominantly single-vessel coronary disease and prior myocardial in-
farction (mean 1 month previously) were studied. Subselective intracoronary
Tc-99m-sestamibi injections were performed at the site of epicardial stenosis
in the infarct-related artery to measure the extent of myocardium at risk (risk
area, RA). A separate injection of sestamibi was performed intravenously at
rest to measure infarct size (IS). RA and IS were determined quantitatively
by circumferential profile analysis using a threshold value of 60% of peak
counts, The ratio of IS/RA was used to reflect the proportion of the area at
risk which was non-viable. IS, RA and IS/RA were then compared with clinical
and angiographic variables.
As expected, a strong correlation was found between IS and RA (r = 0.82,
p < 0.0005); the IS/RA ratio showed an inverse relationship with ejection
fraction by ventriculography (p < 0.02). An IS/RA ratio < 0.6 was predictive
of better global and regional ventricular function and preserved (TIMI grade
3) antegrade or collateral flow (all p < 0.05). No independent relation was
seen between IS/RA or IS and antegrade or collateral flow alone.
Thus: 1) RA size is an important determinant of IS; 2) an IS/RA ratio <
0.6 reflects the presence of residual viable myocardium within the infarct-
related arterial bed. The IS/RA ratio is inversely correlated with clinical and
angiographic indicators of viability. This parameter may provide an indepen-
dent means of assessing viability within a given coronary vascular territory.
Results Ex-injection Early RI Late RI P-value
(75 MBq) (37 MBq) 137 MBq)
peak activity (% of
inilial peak) 100 95 ± 55 76 ± 59 n.s.
residual activity (% of
Initial peak) 8±6 6±7 n.s.
Al' mln-1 (1-10 min) 0.17 ± 0,09 0.14 ± 0.05 0.13 ± 003 n.s.
A2_ min- 1 (11-30 min) 0.029 ± 0.05 0007 ± 0,015 0.003 ± 0011 n.s.
Conclusions: 1. Increase of TI blood concentration after RI of half the ini-
Clearance of Thalllum-201 from the Blood After
Peak Exercise: No Difference in Washout Kinetics
Between Early and Late Reinjection
Berthe L.F. van Eck-Smit, Ernst E. van der Wall. Patrick PA.M. Verhoeven, Aellko
H, Zwinderman. Ernest K,J. Pauwels. University Hospital, Leiden, The Netherlands
Early reinjection (ER) of Thallium-201 (TI) following post exercise (Ex) imaging
has been proposed as an alternative time-saving approach for the evaluation
of patients (pts) with ischemic heart disease, Howeverthe influence of short-
ening the interval between Ex and RI on TI kinetics has not been established
before, The aim of the study was to determine the influence of Ex and the
time interval between Ex and RI at rest on TI clearance from the peripheral
blood. A total of 53 pts were studied. In all pts TI (75 MBq) was injected at
maximal Ex, In 26 pts 37 MBq was reinjected immediately after completing
the Ex-images and in the remaining 27 pts TI (37 MBq) was reinjected after
completing 3-h redistribution images. Venous blood samples were taken at
2-minute intervals during the first 30 min after TI administration and residual
TI activity was measured shortly before RI. From blood activity curves peak
activity, residual activity and decay constants were calculated.
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The Use of Exercise-Rest Same Day SPECr
Sestamibi Imaging Protocol in Coronary Artery
Disease Detection
Joseph Powers, Salah Bahralilom, Joseph Russel, Virginia Cave, Jaekyeong Heo,
Abdulmassih S. Iskandrian. The Philadelphia Heart Institute, Presbyterian Medical
Center, Philadelphia, PA
There are several sestamibi imaging protocols, each with certain perceived
advantages and limitations. Most published reports are on patients (pts) in
clinical trials which may have a hidden bias in pt selection, This study exam-
ined our clinical experience using the exercise (10 mCi)/rest (30 mCi) same
day SPECT protocol with sestamibi in 132 pts with coronary artery disease
(CAD) by angiography and 61 pts with low pre-test probability of CAD. There
were 670 pts studied during the same time period but not included because
they did not meet the above two criteria. The rest study was combined with
first-pass RNA using the Sim-400 gamma camera in 72 pts. There were 112
men and 20 women aged 60 ± 11 years. The pts weight was 179 ± 27 Ibs
and height was 68 ± 3 inches. The exercise was adequate (2: 85% of maxi-
mum predicted heart rate or positive S-T response) in 85 pts and submaximal
in 47 pts. The overall sensitivity of SPECT was 88% (compared to 27% for
S-T depression, P = 0.0001); it was 76% in one-vessel, 84% in two- and
98% in three-vessel disease (P = 0,006). The normalcy rate in 61 pts with
low probability of CAD was 95%. The perfusion defects in 116 pts with ab-
normal images were reversible (complete or partial) in 80 pts and fixed in 36
pts. The left ventricular ejection fraction was 50 ± 12% in pts with reversible
and 39 ± 9% in pts with fixed defects (P = 0.0003). In the 72 pts with RNA,
there were 15 segments with fixed defects. The wall motion was normal in
2 segments, and abnormal in 13. In 129 segments with no fixed defects, the
wall motion was normal in 97 (75%), Thus, the exercise-rest same day ses-
tamibi protocol provides a high diagnostic accuracy for CAD detection and
high quality functional studies. The protocol may also eliminate the need for
rest studies in pts whose exercise studies are normal.
Stress-only Tc99m-Sestamibi Myocardial
Perfusion Imaging in Patients with a Low
Probability of CAD: Short-term Follow-up of a
Streamlined Perfusion Imaging Protocol
Luke F. Daley, Nancie L. Shea, Elizabeth Oates, James E. Udelson. Tufts-New
England Medical Center, Boston, Mass.
To assess image quality of late TI, we prospectively studied 107 patients
who underwent M-DIMPS. For purposes of comparison between conven-
tional DIMPS and M-DIMPS, a subset (group A, n = 41) also had rest TI125
sec/stop, 60 stops) the night before M-DIMPS. Late TI used 30 sec/stop. Pre-
reconstruction processing used a 20 Butterworth filter (cut-off: 0.5/order 10
for rest TI, 0.35/order 10 for late TI). Comparisons were made for cardiac
counts (counts/pixel) and quantitative heart to background ratio (HIB ratio).
Image quality was assessed visually using a 5 point score (0 = unaccept-
able, 4 = excellent), based on the evaluation of image uniformity, defect
clarity, left ventricular border definition and the apparent H/B ratio, Compar-
isons between rest TI and late TI in 41 group A patients yielded quantitative
H/B ratio of 1.63 ± 0.39 and 1.49 ± 0,31 (p = 0.002), and total myocardial
counts of 41.4 ± 18.1 and 29.3 ± 11.6 (p < 0.001), respectively. Image quality
agreement between rest TI and late TI was 90%, with 31 concordant good
to excellent and 6 concordant fair studies. Analysis of the 107 late TI studies
by patient weight revealed:
Traditional scintigraphic assessment of CAD and ischemia has required a
comparison of stress to resting images. In the setting of a high quality nor-
mal stress image, there is conceptually low yield from rest imaging; however
no data are available to support this concept ad to relate the use of this type
of imaging protocol to outcomes. To investigate this type of protocol, we
prospectively evaluated 70 patients, mean age 49 ± 11 years (56% women).
who had a low-to-moderate pre-test probability of CAD 123 ± 22%, based
on Diamond-Forrester criteria prior to stress testing), SPECT imaging was
performed following the injection of 20 mCi Tc99m-sestamibi at peak stress,
Rest imaging was only performed in the setting of abnormal or equivocal
stress images. Of the 70 patients, 83% had treadmill testing; 17% pharmaco-
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